Pancreatic Cancer Research

ResearcherShanghai Jiao Tong UniversityActive in the last 2 years

Guanggai Xia

Matched on OpenAlex author ID A5112904832. Sources: OpenAlex.

Their work

Papers
8
Trials
0
Grants
0
Labs led
0
Collaborators
14
Papers, trials and grants by year

2017: 1 paper · 2018: 1 paper · 2019: 1 paper · 2020: 2 papers · 2021: none · 2022: 1 paper · 2023: 1 paper · 2024: 1 paper

Papers 8

  1. Inhibition of autophagy induced by tetrandrine promotes the accumulation of reactive oxygen species and sensitizes efficacy of tetrandrine in pancreatic cancer. Co-author DOI 10.1186/s12935-024-03410-5↗
  2. Umbelliprenin induces autophagy and apoptosis while inhibits cancer cell stemness in pancreatic cancer cells. Co-author DOI 10.1002/cam4.6170↗
  3. Jumonji-C domain-containing protein 5 suppresses proliferation and aerobic glycolysis in pancreatic cancer cells in a c-Myc-dependent manner. Co-author DOI 10.1016/j.cellsig.2022.110282↗
  4. Survival of pancreatic cancer patients is negatively correlated with age at diagnosis: a population-based retrospective study. Co-author DOI 10.1038/s41598-020-64068-3↗
  5. Combined Exosomal GPC1, CD82, and Serum CA19-9 as Multiplex Targets: A Specific, Sensitive, and Reproducible Detection Panel for the Diagnosis of Pancreatic Ca… Co-author DOI 10.1158/1541-7786.mcr-19-0588↗
  6. Gambogic acid induces autophagy and combines synergistically with chloroquine to suppress pancreatic cancer by increasing the accumulation of reactive oxygen s… Co-author DOI 10.1186/s12935-018-0705-x↗
  7. Localized Controlled Delivery of Gemcitabine via Microsol Electrospun Fibers to Prevent Pancreatic Cancer Recurrence. Co-author DOI 10.1002/adhm.201800593↗
  8. Gambogic acid sensitizes gemcitabine efficacy in pancreatic cancer by reducing the expression of ribonucleotide reductase subunit-M2 (RRM2). Co-author DOI 10.1186/s13046-017-0579-0↗

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongcheng Wang · 5 shared papers, 2017–2024 · strength 0.78
  2. Xinyu Huang · 6 shared papers, 2017–2022 · strength 0.68
  3. Yiwei Wang · 2 shared papers, 2022–2024 · strength 0.47
  4. Jiazhe Liu · 2 shared papers, 2020–2022 · strength 0.32
  5. Xiu−Yan Huang · 3 shared papers, 2017–2020 · strength 0.31
  6. Hongcheng Wang · 2 shared papers, 2018–2023 · strength 0.30
  7. Xinyu Huang · 1 shared paper, 2024 · strength 0.28
  8. Xinyu Huang · 1 shared paper, 2023 · strength 0.22
  9. Dong Xiao · 1 shared paper, 2020 · strength 0.10
  10. Hong Xu · 1 shared paper, 2020 · strength 0.10
  11. Qingcai Meng · 1 shared paper, 2017 · strength 0.08
  12. Hélder A. Santos · 1 shared paper, 2018 · strength 0.08
  13. Hongbo Zhang · 1 shared paper, 2018 · strength 0.08
  14. Wenguo Cui · 1 shared paper, 2018 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.